BRITISH NEURO-ONCOLOGY SOCIETY ANNUAL MEETING 2022

WEDNESDAY 22ND – FRIDAY 24TH JUNE 2022

ORGANISED BY THE WALTON CENTRE NHS FOUNDATION TRUST

This event ensures that all those working in neuro-oncology in the UK meet to learn, discuss and impart findings within a friendly and informative atmosphere.

The multidisciplinary role of BNOS is represented by plenary presentations, discussions, debates, sponsored symposia, oral presentations and posters covering a wide variety of topics which may range from stem cells and in-vitro models to classification and biomarkers, neuro-imaging and neurosurgical techniques, immuno-oncology, quality of life and indicators of patient performance.

THEME | Current, novel and alternatives – Setting the standard

PATIENT VARIABILITY | New approaches to clinical trials will be essential for future precision medicine. We will explore novel trial designs, clinical and radiological annotation of biological data and integration of trials and lab-based research. Combined, these will help identify ‘targeted’ treatments to improve survival and/or quality of life.

EMERGING TREATMENTS | Precision therapeutics, combining advanced pre-clinical models of brain cancer with novel trial methodologies, will be required to develop targeted treatments for individuals. Summarising current state-of-the-art in neurosurgery, chemotherapy and radiotherapy, we will review how tumour microenvironment influences treatment response, and present emerging strategies from immune-oncology to engineering approaches and advanced diagnostics. We will showcase ongoing and emerging clinical trials, and debate the future of brain cancer research.

OPTIMISING OUTCOMES | Working with patient and carers focus groups, we are developing multi-disciplinary programmes to improve patient outcomes and experience. These include pre-habilitation, optimising mental and physical fitness before treatment, a survivor’s programme, helping patients cope with the disease and treatment, and a carer’s programme to help support those looking after brain cancer patients.

@BNOSOfficial

BNOS @BNOSOfficial   4:07 PM - Thu 21 Oct 2021

Preclinical Model Survey Results! @BNOSofficial would like to thank all those who took part in the recently circulated survey on UK Preclinical Models for the Neuro-oncology Community. The results have now been collated and can be viewed here: https://t.co/vkS4VQXxHs

BNOS @BNOSOfficial   1:39 PM - Thu 21 Oct 2021

📢Survey! @EANOassociation Disparity Committee, which is co-chaired by Prof. Susan Short (BNOS VP) are keen to gather opinions from a broad cohort in neuro- oncology around support for positive action to improve EDI. Link & more info here: https://t.co/kiQjTykxL7 Thank you!👏

BNOS @BNOSOfficial   4:12 PM - Wed 20 Oct 2021

#BNOS2021 Abstracts Supplement OUP Neuro-Oncology Online We are pleased to confirm that the Abstracts Supplement, containing the selected BNOS2021 Oral abstracts, has been published with Neuro-Oncology Online. Access here: https://t.co/JQuLyD5u0Z

BNOS @BNOSOfficial   11:55 AM - Tue 12 Oct 2021

📢BNOS Members Discount! MDPI Affiliation @MDPIOpenAccess BNOS is pleased to announce its affiliation with a selection of four MDPI journals. Details here: https://t.co/UwBdAbj5qR Join BNOS here: https://t.co/bJLO4jxpWQ https://t.co/UlFFw51Vfc

BNOS @BNOSOfficial   9:01 AM - Sun 10 Oct 2021

Congratulations to BNOS Vice-President Prof.Susan Short on your EANO Presidency @EANOassociation @prof_short https://t.co/wLCO66f8yq

BNOS @BNOSOfficial   11:01 AM - Fri 8 Oct 2021

Your chance to shine with Brilliance! #BTSM #BrainTumourThursday @theIBTA 👏 https://t.co/dewXr57quN

BNOS @BNOSOfficial   9:30 AM - Fri 8 Oct 2021

Happy 1st Birthday to the BNOS Collaborative Research Consortium! Why not join us? Find out more here: https://t.co/3s6atHTGLa https://t.co/2nVKTtvFCz